Company Performance Metrics
Fay Horak: Chief Scientific Officer- James McNames: Fellow
APDM Wearable Technologies is a digital health company focused on developing and commercializing digital endpoints for neuroscience and balance disorders. APDM has raised $13MM+ from the NIH and Department of Defense, has over 200+ publications and thousands of researchers worldwide using our technology, and are currently involved in 5 active
clinical trials. We have a foundational patent portfolio in wearable technology, which is still active.
APDM is a full stack engineering team (hardware, software, algorithm) with a strong scientific foundation. We are unique in digital health because of our scientific roots, ensuring that all commercial products are rigorously studied and validated by third party researchers.
APDM's future revenue growth (historically since commercialization in 2011 +30% YOY) is set to accelerate over the next 10 years related to the expanding demand for objective, digital endpoints in clinical trials, and ultimately reaching the patient as a companion device to pharmaceutical drugs as the drug delivery landscape continues to adopt more at-home efficacy monitoring.
For more information, please visit our website, www.apdm.com
